Merck’s Januvia Scores European Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm also awaiting a decision in the U.S. on sitagliptin/metformin combination Janumet, expected this week.
You may also be interested in...
Janumet Approved; Type 2 Diabetes Therapy Will Be Available By End Of April
Price for the Januvia/metformin combo will be the same as for Januvia alone, Merck tells “The Pink Sheet” DAILY.
Janumet Approved; Type 2 Diabetes Therapy Will Be Available By End Of April
Price for the Januvia/metformin combo will be the same as for Januvia alone, Merck tells “The Pink Sheet” DAILY.
Galvus “Approvable” Letter Requests Additional Study In Renal Failure Patients
Analysts indicate approval of the type 2 diabetes therapy could be delayed for a year or more.